VYVGART Hytrulo
Active substance: EFGARTIGIMOD ALFA, HYALURONIDASE (HUMAN RECOMBINANT)
INJECTION, SOLUTION · EFGARTIGIMOD ALFA 180 mg/mL, HYALURONIDASE (HUMAN RECOMBINANT) 2000 U/mL
United StatesActive
Marketing holder: argenx US
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- EFGARTIGIMOD ALFA · 180 mg/mL
- HYALURONIDASE (HUMAN RECOMBINANT) · 2000 U/mL
Products containing efgartigimod alfa in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12090-f125-7f2a-9fd3-82de2c9383b2;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 73475-3102
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 73475-3102 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 73475-3102 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 73475-3102 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 73475-3102 · Verified 2026-10-09 · open in source